Jens Otto Lunde Jørgensen Selected Research

acipimox

1/2019	Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients.
12/2017	Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation.
1/2017	Acyl Ghrelin Induces Insulin Resistance Independently of GH, Cortisol, and Free Fatty Acids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens Otto Lunde Jørgensen Research Topics

Disease

21	Insulin Resistance 01/2020 - 11/2002
9	Neoplasms (Cancer) 01/2022 - 03/2007
8	Acromegaly 12/2018 - 12/2003
8	Hyperthyroidism 07/2010 - 10/2002
6	Obesity 10/2019 - 02/2002
4	Adrenal Insufficiency (Adrenal Gland Hypofunction) 09/2019 - 01/2005
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 04/2010
3	Hypopituitarism (Sheehan's Syndrome) 12/2018 - 08/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 03/2006
2	Cushing Syndrome 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 07/2013
2	Overweight 01/2019 - 07/2014
2	Adenoma (Adenomas) 12/2018 - 10/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 10/2008
2	Hyperinsulinism (Hyperinsulinemia) 06/2013 - 02/2003
2	Hypothyroidism 08/2010 - 07/2010
2	Hypoglycemia (Reactive Hypoglycemia) 04/2009 - 09/2007
2	Weight Loss (Weight Reduction) 09/2007 - 02/2002
1	Carcinogenesis 01/2022
1	Diabetes Insipidus 12/2020
1	Polyuria 12/2020
1	Polydipsia 12/2020
1	Necrosis 09/2019
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2017
1	Hyperplasia 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2015
1	Fibrosis (Cirrhosis) 08/2015
1	Hyperprolactinemia 01/2014
1	Prolactinoma (Prolactinomas) 01/2014
1	Rare Diseases (Rare Disease) 01/2014
1	Metabolic Diseases (Metabolic Disease) 07/2013
1	Non-alcoholic Fatty Liver Disease 07/2013
1	Hyperglycemia 06/2013
1	Inappropriate ADH Syndrome (SIADH) 04/2012
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 08/2010

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2002
10	Insulin (Novolin)FDA Link 01/2019 - 10/2002
9	GhrelinIBA 01/2020 - 02/2002
8	Growth Hormone (Somatotropin)IBA 01/2022 - 11/2002
7	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2003
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 11/2002
5	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 03/2006
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2016 - 10/2005
4	GlucocorticoidsIBA 01/2022 - 01/2019
4	LipidsIBA 07/2014 - 10/2002
4	Thyroid HormonesIBA 07/2010 - 06/2005
3	acipimoxIBA 01/2019 - 01/2017
3	ResveratrolIBA 01/2017 - 07/2013
2	Insulin-Like PeptidesIBA 01/2022 - 12/2018
2	Vasopressins (Vasopressin)IBA 12/2020 - 04/2012
2	Muscle Proteins (Muscle Protein)IBA 01/2020 - 06/2005
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2019
2	Hormones (Hormone)IBA 01/2019 - 10/2008
2	Messenger RNA (mRNA)IBA 08/2015 - 07/2010
2	PalmitatesIBA 07/2014 - 08/2010
2	Glycerol (Glycerine)FDA LinkGeneric 06/2013 - 10/2002
2	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2010 - 11/2005
2	Amino Acids FDA Link 10/2008 - 06/2005
2	Urea (Carbamide)FDA LinkGeneric 09/2007 - 10/2003
2	Somatotropin Receptors (Growth Hormone Receptor)IBA 03/2007 - 10/2005
2	pegvisomant FDA LinkGeneric 03/2007 - 10/2005
2	Dehydroepiandrosterone (DHEA)IBA 03/2007 - 01/2005
2	AndrogensIBA 03/2007 - 01/2005
2	Methimazole (Thiamazole)FDA LinkGeneric 11/2005 - 06/2005
1	Arginine (L-Arginine)FDA Link 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Biological ProductsIBA 09/2019
1	Azathioprine (Imuran)FDA LinkGeneric 09/2019
1	Methotrexate (Mexate)FDA LinkGeneric 09/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019
1	Insulin ReceptorIBA 01/2019
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2019
1	HexokinaseIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	IncretinsIBA 01/2019
1	Glucose-6-PhosphateIBA 01/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	acyl-ghrelinIBA 01/2017
1	Estrogen ReceptorsIBA 04/2016
1	PolyphenolsIBA 09/2015
1	Gonadal Steroid Hormones (Sex Hormones)IBA 09/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2015
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2015
1	Insulin-Like Growth Factor Binding ProteinsIBA 08/2015
1	Oxygen (Dioxygen)IBA 11/2014
1	Cabergoline FDA LinkGeneric 01/2014
1	Tolvaptan FDA Link 04/2012
1	Triglycerides (Triacylglycerol)IBA 08/2010
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 08/2010

Therapy/Procedure

4	Therapeutics 01/2019 - 11/2005
3	Aftercare (After-Treatment) 01/2022 - 12/2003
2	Intravenous Infusions 12/2020 - 06/2013
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2020
1	Bed Rest (Bedrest) 01/2020
1	Combined Modality Therapy 12/2017
1	Continuity of Patient Care 01/2014